Related Experiment Videos
PET-scan in colorectal cancer
1Department of Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium. max.lonneux@imre.ucl.ac.be
Acta Chirurgica Belgica
|September 28, 2005
Summary
Positron emission tomography (PET) with FDG effectively detects colorectal cancer, aids in staging, monitors treatment response, and identifies disease recurrence. This review covers the physical and biological principles of PET-FDG imaging in oncology.
Area of Science:
- Nuclear medicine
- Oncologic imaging
- Molecular imaging
Background:
- Positron emission tomography (PET) is an advanced imaging technique.
- Fluorodeoxyglucose (FDG) is a glucose analogue used as a radiotracer in PET scans.
- Colorectal cancer (CRC) is a significant global health concern.
Purpose of the Study:
- To review the current applications of FDG PET imaging in colorectal cancer.
- To evaluate the role of PET-FDG in various stages of CRC management.
Main Methods:
- Review of existing literature on PET-FDG in colorectal cancer.
- Analysis of PET-FDG utility for detection, staging, therapy monitoring, and relapse assessment.
Main Results:
- PET-FDG demonstrates significant value in the detection of colorectal cancer.
- The technique is crucial for accurate initial staging and restaging of the disease.
- PET-FDG is effective in monitoring treatment response and detecting recurrence.
Conclusions:
- FDG PET imaging is a valuable tool in the comprehensive management of colorectal cancer.
- Its application spans from initial diagnosis to post-treatment surveillance.